Skip to main content
SpringerLink
Log in

Endometrial Cancer: Risk Factors and Early Diagnosis in Low-Resource Countries

  • Chapter
  • First Online:
Breast and Gynecological Cancers

Abstract

Many risk factors are recognized for the development of endometrial ­cancer (EMC). A strong risk factor for hereditary nonpolyposis colonic cancer is an indication for EMC screening. Any women at risk must be counseled and evaluated in detail about their risk for many cancers, especially colonic and EMC. This is usually done in higher levels of health service rather than in a low resource setting. Also, the data concerning risk have been derived in these higher resource settings and are not necessarily transferable to other populations. For EMC, the screening methods ­comprise an annual transvaginal ultrasound beginning at 30–35 years of age and periodic endometrial sampling. EMC screening is not recommended in any woman with low or moderate risk or those without familial predisposition. Nevertheless, patients should be educated for the signs or symptoms suggesting an endometrial lesion, such as postmenopausal bleeding. An endometrial biopsy with a small cannula is considered an initial diagnostic step. This procedure can be performed in an out-patient setting while uterine curettage is reserved for a woman with inadequate, inconclusive, or hyperplasic tissue from endometrial biopsy. Transvaginal ultrasonography may be useful as an adjunct in selected cases depending on the availability, physician training, or resource setting. Hysteroscopy, as a diagnostic and therapeutic maneuver, requires specialized operative skill and may not be available in limited health care environments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  PubMed  CAS  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  3. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13:295–308.

    Article  PubMed  CAS  Google Scholar 

  4. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008;111:436–47.

    Article  PubMed  Google Scholar 

  5. Tangjitgamol S, Anderson BO, See HT, Lertbutsayanukul C, Sirisabya N, Manchana T, et al. Asian Oncology Summit. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1119–27.

    Article  PubMed  Google Scholar 

  6. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113:2221–43.

    Article  PubMed  Google Scholar 

  7. Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol. 1989;161:1859–64.

    PubMed  CAS  Google Scholar 

  8. Persson I, Adami HO, Bergkvist L, Lindgren A, Pettersson B, Hoover R, et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ. 1989;298:147–51.

    Article  PubMed  CAS  Google Scholar 

  9. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control. 1999;10:253–60.

    Article  PubMed  CAS  Google Scholar 

  10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Article  PubMed  CAS  Google Scholar 

  11. Aiman J, Forney JP, Parker Jr CR. Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women. Obstet Gynecol. 1986;68:1–5.

    Article  PubMed  CAS  Google Scholar 

  12. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol. 1983;61:403–7.

    PubMed  CAS  Google Scholar 

  13. Silverberg SG. Hyperplasia and carcinoma of the endometrium. Semin Diagn Pathol. 1988;5:135–53.

    PubMed  CAS  Google Scholar 

  14. Fenoglio CM, Crum CP, Ferenczy A. Endometrial hyperplasia and carcinoma. Are ultrastructural, biochemical and immunocytochemical studies useful in distinguishing between them? Pathol Res Pract. 1982;174:257–84.

    Article  PubMed  CAS  Google Scholar 

  15. Sherman ME, Silverberg SG. Advances in endometrial pathology. Clin Lab Med. 1995;15:517–43.

    PubMed  CAS  Google Scholar 

  16. Silverberg SG. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol. 2000;13:309–27.

    Article  PubMed  CAS  Google Scholar 

  17. Kendall BS, Ronnnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well differentiated carcinoma. Am J Surg Pathol. 1998;22:1012–9.

    Article  PubMed  CAS  Google Scholar 

  18. Trimble C, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812–9.

    Article  PubMed  Google Scholar 

  19. Committee on Gynecologic Practice, The American College of Obstetricians and Gynecologists. ACOG committee opinion. Tamoxifen and endometrial cancer. Int J Gynecol Obstet. 2006;107:1475–8.

    Article  Google Scholar 

  20. Formander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfverswärd C, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989;2:117–20.

    Article  Google Scholar 

  21. Andersson M, Storm HH, Mouridse HT. Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer. Acta Oncol. 1992;31:259–63.

    Article  PubMed  CAS  Google Scholar 

  22. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86:527–37.

    Article  PubMed  CAS  Google Scholar 

  23. Curtis RE, Boice Jr JD, Shriner DA, et al. Second cancer after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst. 1996;88:8332–4.

    Google Scholar 

  24. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol. 2004;94:256–66.

    Article  PubMed  CAS  Google Scholar 

  25. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol. 1993;11:485–90.

    PubMed  CAS  Google Scholar 

  26. Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11:1135–41.

    Article  PubMed  CAS  Google Scholar 

  27. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.

    Article  PubMed  Google Scholar 

  28. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006;106:2376–81.

    Article  PubMed  CAS  Google Scholar 

  29. Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen X, et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol. 2010;117:41–6.

    Article  PubMed  CAS  Google Scholar 

  30. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009;16:14–22.

    PubMed  Google Scholar 

  31. Ollikainen M, Abdel-Rahman WM, Moisio AL, Lindroos A, Kariola R, Järvelä I, et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol. 2005;23:4609–16.

    Article  PubMed  CAS  Google Scholar 

  32. Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P, et al. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010;127:2678–84.

    Article  PubMed  CAS  Google Scholar 

  33. Beiner ME, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol. 2007;104:7–10.

    Article  PubMed  CAS  Google Scholar 

  34. Parazzini F, Negri E, La Vecchia C, Benzi G, Chiaffarino F, Polatti A, et al. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer. 1998;76:784–6.

    Article  PubMed  CAS  Google Scholar 

  35. Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, et al. Low-fat dietary pattern and cancer incidence in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007;99:1534–43.

    Article  PubMed  Google Scholar 

  36. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82:145–8. quiz 265.

    Article  PubMed  CAS  Google Scholar 

  37. Setiawan VW, Monroe KR, Goodman MT, Kolonel LN, Pike MC, Henderson BE. Alcohol consumption and endometrial cancer risk: the multiethnic cohort. Int J Cancer. 2008;122:634–8.

    Article  PubMed  CAS  Google Scholar 

  38. Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, La Vecchia C, et al. Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol. 2009;200:130–5.

    Article  PubMed  Google Scholar 

  39. Tang NP, Li H, Qiu YL, Zhou GM, Ma J. Tea consumption and risk of endometrial cancer: a metaanalysis. Am J Obstet Gynecol. 2009;201:605.e1–8.

    Article  Google Scholar 

  40. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41.

    Article  PubMed  Google Scholar 

  41. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.

    Article  PubMed  CAS  Google Scholar 

  42. Brown GJ, St John DJ, Macrae FA, Aittomäki K. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol. 2001;80:346–9.

    Article  PubMed  CAS  Google Scholar 

  43. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507–17.

    Article  PubMed  CAS  Google Scholar 

  44. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481–7.

    Article  PubMed  CAS  Google Scholar 

  45. Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol. 2007;25:5158–64.

    Article  PubMed  CAS  Google Scholar 

  46. Wright TC, Massad S, Dunton C, Spitzer M, Wilkinson EJ, Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathology—sponsored Consensus Conference ASCCP. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346–55.

    Article  Google Scholar 

  47. Sorosky JI. Endometrial Cancer. Obstet Gynecol. 2012;120:383–97.

    Article  PubMed  Google Scholar 

  48. Karlsson B, Granberg S, Wikland M, Ylöstalo P, Torvid K, Marsal K, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. Am J Obstet Gynecol. 1995;172:1488–94.

    Article  PubMed  CAS  Google Scholar 

  49. Goldstein S. The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. Am J Obs Gyn. 2009;201:5–11.

    Article  Google Scholar 

  50. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89:1765–72.

    Article  PubMed  CAS  Google Scholar 

  51. Lipscomb GH, Lopatine SM, Stovall TG, Ling FW. A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices. Am J Obstet Gynecol. 1994;170:591–4.

    PubMed  CAS  Google Scholar 

  52. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol. 1995;86:38–42.

    Article  PubMed  CAS  Google Scholar 

  53. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95:463–8.

    Article  PubMed  Google Scholar 

  54. Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia. Acta Obstet Gynecol Scand. 2001;80:784–93.

    Article  PubMed  CAS  Google Scholar 

  55. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients. Int J Gynecol Cancer. 2000;10:275–9.

    Article  PubMed  Google Scholar 

  56. Nalaboff KM, Pellerito JS, Ben-Levi E. Imaging the endometrium: disease and normal variants. Radiographics. 2001;21:1409–24.

    PubMed  CAS  Google Scholar 

  57. Zalud I, Conway C, Schulman H, et al. Endometrial and myometrial thickness and uterine blood low in postmenopausal women: the influence of hormonal replacement therapy and age. J Ultrasound Med. 1993;12:737–41.

    PubMed  CAS  Google Scholar 

  58. Fleischer AC. Sonographic assessment of endometrial disorders. Semin Ultrasound CT MR. 1999;20:259–66.

    Article  PubMed  CAS  Google Scholar 

  59. Sahakain V, Syrop C, Turner D. Endometrial carcinoma: transvaginal ultrasonography prediction of depth of myometrial invasion. Gynecol Oncol. 1991;43:217–9.

    Article  Google Scholar 

  60. Savelli L, Testa AC, Mabrouk M, Zannoni L, Ludovisi M, Seracchioli R, et al. A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer. Gynecol Oncol. 2012;124(3):549–52.

    Article  PubMed  Google Scholar 

  61. Ozdemir S, Celik C, Emlik D, Kiresi D, Esen H. Assessment of myometrial invasion in endometrial cancer by transvaginal sonography, Doppler ultrasonography, magnetic resonance imaging and frozen section. Int J Gynecol Cancer. 2009;19(6):1085–90.

    Article  PubMed  Google Scholar 

  62. Dubinsky TJ. Value of sonography in the diagnosis of abnormal vaginal bleeding. J Clin Ultrasound. 2004;32:348–53.

    Article  PubMed  Google Scholar 

  63. Gull B, Carlsson SA, Karlsson B, et al. Transvaginal ultrasound in the endometrium in women with post-menopausal bleeding: is it always necessary to perform an endometrial biopsy? Am J Obstet Gynecol. 2000;182:509.

    Article  PubMed  CAS  Google Scholar 

  64. Einerth Y. Vacuum curettage by the Vabrar method: a simple procedure for endometrial diagnosis. Acta Obstet Gynecol Scand. 1982;61:373–6.

    PubMed  CAS  Google Scholar 

  65. Lidor A, Ismajovich B, Confino E, David MP. Histopathological findings in 226 women with postmenopausal uterine bleeding. Acta Obstet Gynecol Scand. 1986;65:41–3.

    Article  PubMed  CAS  Google Scholar 

  66. Ferenczy A, Shore M, Guralnick M, Gelfand MM. The Kevorkian curette: an appraisal of its effectiveness in endometrial evaluation. Obstet Gynecol. 1979;54:262–7.

    PubMed  CAS  Google Scholar 

  67. Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol. 1991;77:954–6.

    PubMed  CAS  Google Scholar 

  68. Medverd JR, Dubinsky TJ. Cost analysis model: US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding. Radiology. 2002;222:619–27.

    Article  PubMed  Google Scholar 

  69. Gull B, Karlsson B, Milsom I, Granberg S. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol. 2003;188:401–8.

    Article  PubMed  CAS  Google Scholar 

  70. Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound—sponsored consensus conference statement. J Ultrasound Med. 2001;20:1025–36.

    PubMed  CAS  Google Scholar 

  71. Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116(1):168–76.

    Article  PubMed  Google Scholar 

  72. Burbos N, Musonda P, Crocker SG, Morris EP, Nieto JJ, Duncan TJ. Management of postmenopausal women with vaginal bleeding when the endometrium cannot be visualized. Acta Obstet Gynecol Scand. 2012;91(6):686–91.

    Article  PubMed  Google Scholar 

  73. Fleischer AC, Wheeler JE, Lindsay I, et al. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol. 2001;184:70–5.

    Article  PubMed  CAS  Google Scholar 

  74. Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12:38–48.

    Article  PubMed  Google Scholar 

  75. Smith-Bindman R, Kerlikowske K, Feldstein VA. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280(17):1510–7.

    Article  PubMed  CAS  Google Scholar 

  76. Burbos N, Musonda P, Crocker SG, Morris EP, Nieto JJ, Duncan TJ. Outcome of investigations for postmenopausal vaginal bleeding in women under the age of 50 years. Gynecol Oncol. 2012;125(1):120–3.

    Article  PubMed  Google Scholar 

  77. Alcazar JL, Galvan R. Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium. Am J Obstet Gynecol. 2009;200:44.e1–6.

    Article  Google Scholar 

  78. Galvan R, Merce L, Jurado M, et al. Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics. Ultrasound Obstet Gynecol. 2010;35:723–9.

    PubMed  CAS  Google Scholar 

  79. Liu ZZ, Jiang YX, Dai Q, Yang M, Zhu QL, Zhao DC, et al. Imaging of endometrial carcinoma using contrast-enhanced sonography. J Ultrasound Med. 2011;30(11):1519–27.

    PubMed  Google Scholar 

  80. Lieng M, Qvigstad E, Dahl GF, Istre O. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol. 2008;32(7):935–40.

    Article  PubMed  CAS  Google Scholar 

  81. Song Y, Yang J, Liu Z, Shen K. Preoperative evaluation of endometrial carcinoma by contrast-enhanced ultrasonography. BJOG. 2009;116(2):294–8; discussion 298–9.

    Article  PubMed  CAS  Google Scholar 

  82. Ferrazzi E, Zupi E, Leone FP, Savelli L, Omodei U, Moscarini M, et al. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol. 2009;200:235.e1–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Vajira Hospital, Bangkok, 10300, Thailand

    Siriwan Tangjitgamol

  2. Department of Obstetrics and Gynecology, Chulalongkorn University, Bangkok, 10330, Thailand

    John Kavanagh

  3. Woman’s Center for Breast Care and MRI, Woman’s Hospital of Texas, Houston, TX, 77054, USA

    Mahesh K. Shetty

Authors
  1. Siriwan Tangjitgamol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Kavanagh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahesh K. Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahesh K. Shetty .

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, Baylor Plaza 1, Houston, 77030, Texas, USA

    Mahesh K. Shetty

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tangjitgamol, S., Kavanagh, J., Shetty, M.K. (2013). Endometrial Cancer: Risk Factors and Early Diagnosis in Low-Resource Countries. In: Shetty, M. (eds) Breast and Gynecological Cancers. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1876-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1876-4_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1875-7

  • Online ISBN: 978-1-4614-1876-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation